LEUKEMIA ACUTE PROMYELOCYTIC LEUKEMIA (APL)

Clinical trials for LEUKEMIA ACUTE PROMYELOCYTIC LEUKEMIA (APL) explained in plain language.

Never miss a new study

Get alerted when new LEUKEMIA ACUTE PROMYELOCYTIC LEUKEMIA (APL) trials appear

Sign up with your email to follow new studies for LEUKEMIA ACUTE PROMYELOCYTIC LEUKEMIA (APL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Could a pill replace hospital infusions for leukemia patients?

Disease control Not yet recruiting

This study is testing if a new pill form of arsenic trioxide works as well as the standard intravenous (IV) infusion for treating a specific type of leukemia called acute promyelocytic leukemia (APL). The goal is to see if the pill is absorbed similarly, is safe, and controls the…

Matched conditions: LEUKEMIA ACUTE PROMYELOCYTIC LEUKEMIA (APL)

Phase: PHASE3 • Sponsor: SDK Therapeutics, Inc. • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

LEUKEMIA ACUTE PROMYELOCYTIC LEUKEMIA (APL)

Get alerted when new LEUKEMIA ACUTE PROMYELOCYTIC LEUKEMIA (APL) trials appear

Could a pill replace hospital infusions for leukemia patients?